These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel ...

The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand ...

Multivalent agents (including antibodies, soluble receptors and cytokines) address immune suppression and T cell exhaustion ...

Learn how soluble B-cell maturation antigen contributes to the effectiveness of targeted immunotherapies.

Recent advancements in dermatology have highlighted the crucial role of dermal T cell immunity in regulating hair follicle ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...

BriaCell's subsidiary, BriaPro seeks patent for immuno-oncology platform with novel multitargeting agents: Philadelphia Thursday, July 31, 2025, 17:00 Hrs [IST] BriaCell Therapeut ...

Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone ...